8 studies found for:    abt700
Show Display Options
Rank Status Study
1 Recruiting Study of ABT-700 in Subjects With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: ABT-700;   Drug: docetaxel;   Drug: FOLFIRI;   Drug: cetuximab;   Drug: erlotinib
2 Terminated Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Biological: Placebo;   Biological: ABT-874
3 Terminated Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Conditions: Hepatocellular Carcinoma Non-resectable;   Hepatocellular Carcinoma Recurrent;   Carcinoma, Hepatocellular;   Liver Diseases;   Neoplasms by Histologic Type;   Digestive System Neoplasms;   Carcinoma;   Liver Neoplasms;   Neoplasms;   Neoplasms by Site;   Digestive System Diseases;   Adenocarcinoma;   Neoplasms, Glandular and Epithelial
Interventions: Drug: ABT-869;   Drug: Sorafenib
4 Completed Phase 1 BA Study, Single Center With Healthy Volunteers
Condition: Healthy
Intervention: Drug: ABT-874
5 Unknown  Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Ritonavir;   Drug: GW433908
6 Completed A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: SLV354
7 Active, not recruiting Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Interventions: Drug: Azacitidine;   Drug: Conventional Care Regimen
8 Completed
Has Results
Aztreonam Lysine for Pseudomonas Infection Eradication Study
Condition: Cystic Fibrosis
Intervention: Drug: Aztreonam for Inhalation Solution (AZLI)

Indicates status has not been verified in more than two years